Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Biomet names CEO: Former Abbott exec Jeffrey Binder succeeds interim CEO Daniel Hann in the top spot at Biomet on Feb. 26. Hann, who will stay with Biomet as executive VP of administration and a member of the board, was named acting CEO in March 2006 when co-founder Dane Miller abruptly resigned (1"The Gray Sheet" April 3, 2006, In Brief). Binder takes over shortly after Biomet agreed to be acquired by an investor consortium for $10.9 billion, or $44 a share (2"The Gray Sheet" Jan. 2007, p. 6). The 15-year orthopedics industry veteran is no stranger to transitioning leadership. Binder supervised the integration of DePuy Orthopedics into Johnson & Johnson in 1998 and served as president of DePuy's joint reconstruction and trauma group until 2000, when he became CEO of Spinal Concepts. That firm was acquired by Abbott in 2003 (3"The Gray Sheet" June 9, 2003, p. 25). Binder led Abbott Spine until Jan. 2006, when he was named VP diagnostic operations. Abbott recently sold its core in vitro diagnostics unit to GE for $8.13 billion (4"The Gray Sheet" Jan. 22, 2007, p. 3)...

You may also be interested in...



People In Brief

CMS payment group: Jeffrey B. Rich, M.D., will be the new director of CMS' Center for Medicare Management starting Feb. 18. CMM is charged with establishing and overseeing the agency's payment policies and is primarily responsible for implementing ongoing reforms including durable medical equipment competitive bidding and pay-for-performance. Rich is a practicing cardiothoracic surgeon and director-at-large for the Society of Thoracic Surgeons. He has been involved in pay-for-performance initiatives through his work with the National Quality Forum, the Hospital Quality Alliance and the AQA (formerly known as the Ambulatory Care Quality Alliance). CMM has not had a permanent director since Herb Kuhn moved up in ranks to deputy administrator of CMS in late 2006 (1"The Gray Sheet" March 5, 2007, p. 7). Current CMM Acting Director Liz Richter will become the group's permanent deputy

People In Brief

CMS payment group: Jeffrey B. Rich, M.D., will be the new director of CMS' Center for Medicare Management starting Feb. 18. CMM is charged with establishing and overseeing the agency's payment policies and is primarily responsible for implementing ongoing reforms including durable medical equipment competitive bidding and pay-for-performance. Rich is a practicing cardiothoracic surgeon and director-at-large for the Society of Thoracic Surgeons. He has been involved in pay-for-performance initiatives through his work with the National Quality Forum, the Hospital Quality Alliance and the AQA (formerly known as the Ambulatory Care Quality Alliance). CMM has not had a permanent director since Herb Kuhn moved up in ranks to deputy administrator of CMS in late 2006 (1"The Gray Sheet" March 5, 2007, p. 7). Current CMM Acting Director Liz Richter will become the group's permanent deputy

CMS Outpatient Packaging Proposal Faces Resistance From Device Makers

CMS has set a course for grouping hospital outpatient payments together in "packages" in an effort to reign in soaring costs, but device stakeholders are urging the agency to scale back the scope and urgency of its plan

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel